178 related articles for article (PubMed ID: 34277606)
1. HNRNPA2B1 Affects the Prognosis of Esophageal Cancer by Regulating the miR-17-92 Cluster.
Li K; Chen J; Lou X; Li Y; Qian B; Xu D; Wu Y; Ma S; Zhang D; Cui W
Front Cell Dev Biol; 2021; 9():658642. PubMed ID: 34277606
[TBL] [Abstract][Full Text] [Related]
2. m
Guo H; Wang B; Xu K; Nie L; Fu Y; Wang Z; Wang Q; Wang S; Zou X
Front Oncol; 2020; 10():553045. PubMed ID: 33134163
[TBL] [Abstract][Full Text] [Related]
3. HNRNPA2B1 inhibited SFRP2 and activated Wnt-β/catenin via m6A-mediated miR-106b-5p processing to aggravate stemness in lung adenocarcinoma.
Rong L; Xu Y; Zhang K; Jin L; Liu X
Pathol Res Pract; 2022 May; 233():153794. PubMed ID: 35364458
[TBL] [Abstract][Full Text] [Related]
4. Identification of clinical prognostic features of esophageal cancer based on m6A regulators.
Wang H; Zhang Y; Chen L; Liu Y; Xu C; Jiang D; Song Q; Wang H; Wang L; Lin Y; Chen Y; Chen J; Xu Y; Hou Y
Front Immunol; 2022; 13():950365. PubMed ID: 36159855
[TBL] [Abstract][Full Text] [Related]
5. Construction and Validation of an m6A RNA Methylation Regulators-Based Prognostic Signature for Esophageal Cancer.
Xu LC; Pan JX; Pan HD
Cancer Manag Res; 2020; 12():5385-5394. PubMed ID: 32753956
[TBL] [Abstract][Full Text] [Related]
6. Comprehensive analysis of m6A RNA methylation regulators in esophageal carcinoma.
Yang H; Liu J; Li L; Wang X; Li Z
Transl Cancer Res; 2024 Jan; 13(1):381-393. PubMed ID: 38410211
[TBL] [Abstract][Full Text] [Related]
7. Activation of the HNRNPA2B1/
Sun M; Shen Y; Jia G; Deng Z; Shi F; Jing Y; Xia S
J Cancer; 2023; 14(7):1242-1256. PubMed ID: 37215455
[TBL] [Abstract][Full Text] [Related]
8. m6A Regulators Is Differently Expressed and Correlated With Immune Response of Esophageal Cancer.
Zhao H; Xu Y; Xie Y; Zhang L; Gao M; Li S; Wang F
Front Cell Dev Biol; 2021; 9():650023. PubMed ID: 33748145
[TBL] [Abstract][Full Text] [Related]
9. HNRNPA2B1 promotes multiple myeloma progression by increasing AKT3 expression via m6A-dependent stabilization of ILF3 mRNA.
Jiang F; Tang X; Tang C; Hua Z; Ke M; Wang C; Zhao J; Gao S; Jurczyszyn A; Janz S; Beksac M; Zhan F; Gu C; Yang Y
J Hematol Oncol; 2021 Apr; 14(1):54. PubMed ID: 33794982
[TBL] [Abstract][Full Text] [Related]
10. Comprehensive analysis of the expression of N6-methyladenosine RNA methylation regulators in pulmonary artery hypertension.
Zheng H; Hua J; Li H; He W; Chen X; Ji Y; Li Q
Front Genet; 2022; 13():974740. PubMed ID: 36171892
[No Abstract] [Full Text] [Related]
11. Dysregulated m6A-Related Regulators Are Associated With Tumor Metastasis and Poor Prognosis in Osteosarcoma.
Li J; Rao B; Yang J; Liu L; Huang M; Liu X; Cui G; Li C; Han Q; Yang H; Cui X; Sun R
Front Oncol; 2020; 10():769. PubMed ID: 32582536
[No Abstract] [Full Text] [Related]
12. A Risk Score Model Incorporating Three m6A RNA Methylation Regulators and a Related Network of miRNAs-m6A Regulators-m6A Target Genes to Predict the Prognosis of Patients With Ovarian Cancer.
Li Q; Ren CC; Chen YN; Yang L; Zhang F; Wang BJ; Zhu YH; Li FY; Yang J; Zhang ZA
Front Cell Dev Biol; 2021; 9():703969. PubMed ID: 34631700
[TBL] [Abstract][Full Text] [Related]
13. Pan-Cancer Prognostic, Immunity, Stemness, and Anticancer Drug Sensitivity Characterization of N6-Methyladenosine RNA Modification Regulators in Human Cancers.
Li R; Yin YH; Ji XL; Liu X; Li JP; Qu YQ
Front Mol Biosci; 2021; 8():644620. PubMed ID: 34150845
[TBL] [Abstract][Full Text] [Related]
14. HNRNPA2B1-Mediated MicroRNA-92a Upregulation and Section Acts as a Promising Noninvasive Diagnostic Biomarker in Colorectal Cancer.
Li Y; Li K; Lou X; Wu Y; Seery S; Xu D; Pei Y; Qian B; Wu Y; Liang S; Wu K; Cui W
Cancers (Basel); 2023 Feb; 15(4):. PubMed ID: 36831695
[TBL] [Abstract][Full Text] [Related]
15. Exploring diagnostic m6A regulators in endometriosis.
Jiang L; Zhang M; Wu J; Wang S; Yang X; Yi M; Zhang X; Fang X
Aging (Albany NY); 2020 Nov; 12(24):25916-25938. PubMed ID: 33232273
[TBL] [Abstract][Full Text] [Related]
16. Upregulation of M6A Reader HNRNPA2B1 Associated with Poor Prognosis and Tumor Progression in Lung Adenocarcinoma.
Wang W; Li S
Recent Pat Anticancer Drug Discov; 2023 Oct; ():. PubMed ID: 37877146
[TBL] [Abstract][Full Text] [Related]
17. The Role of m
Li Y; Niu C; Wang N; Huang X; Cao S; Cui S; Chen T; Huo X; Zhou R
Cancers (Basel); 2022 Oct; 14(20):. PubMed ID: 36291923
[TBL] [Abstract][Full Text] [Related]
18. Cholesterol homeostasis confers glioma malignancy triggered by hnRNPA2B1-dependent regulation of SREBP2 and LDLR.
Zhang J; Liu B; Xu C; Ji C; Yin A; Liu Y; Yao Y; Li B; Chen T; Shen L; Wu Y
Neuro Oncol; 2024 Apr; 26(4):684-700. PubMed ID: 38070488
[TBL] [Abstract][Full Text] [Related]
19. Comprehensive Analysis of Hexokinase 2 Immune Infiltrates and m6A Related Genes in Human Esophageal Carcinoma.
Liu XS; Liu JM; Chen YJ; Li FY; Wu RM; Tan F; Zeng DB; Li W; Zhou H; Gao Y; Pei ZJ
Front Cell Dev Biol; 2021; 9():715883. PubMed ID: 34708035
[No Abstract] [Full Text] [Related]
20. Development of a prognostic prediction model based on microRNA-1269a in esophageal cancer.
Yu Y; Ren KM
World J Gastrointest Oncol; 2021 Aug; 13(8):943-958. PubMed ID: 34457197
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
